Financhill
Back

Vanda Pharmaceuticals Quote, Financials, Valuation and Earnings

U.S. Government Report Alert Tuesday

Discover the Secret Loophole
Sell
37

VNDA
Vanda Pharmaceuticals

Last Price:
4.89
Seasonality Move:
7.58%

7 Day Trial

ALL ACCESS PASS

$ 7

Yours Free! Top SIX AI Dividend Stocks Right Now

NO CREDIT CARD REQUIRED!

Vanda Pharmaceuticals Price Quote

$4.89
+0.10 (+2.09%)
(Updated: November 6, 2024 at 5:55 PM ET)

Vanda Pharmaceuticals Key Stats

Sell
37
Vanda Pharmaceuticals (VNDA) is a Sell

Day range:
$4.66 - $4.80
52-week range:
$3.30 - $6.75
Dividend yield:
0%
P/E ratio:
119.75
P/S ratio:
1.52
P/B ratio:
0.51%

Volume:
591.4K
Avg. volume:
582.8K
1-year change:
5.97%
Market cap:
$279.2M
Revenue:
$192.6M
EPS:
$-0.19

How Much Does Vanda Pharmaceuticals Make?

Is Vanda Pharmaceuticals Growing As A Company?

  • What Is Vanda Pharmaceuticals's Growth Rate Quarterly?
    Quarterly YoY revenue growth is 0.1%
  • What Is Vanda Pharmaceuticals's EPS Quarterly YoY Growth Rate?
    Quarterly, year-over-year diluted EPS growth rate is 0%

Vanda Pharmaceuticals Stock Price Performance

What Is Vanda Pharmaceuticals 52-Week High & Low?

Vanda Pharmaceuticals Price To Free Cash Flow

Data Unavailable

Is It Risky To Buy Vanda Pharmaceuticals?

Is Vanda Pharmaceuticals Cash Flow Positive?

  • What Is VNDA Cash Flow From Operations?
    Cash flow from operations (TTM) is -$5.1M
  • What Is Vanda Pharmaceuticals’s Cash Flow From Financing?
    Cash flow from financing (TTM) is $0
  • What Is Vanda Pharmaceuticals’s Cash Flow From Investing?
    Cash flow from investing (TTM) is -$41.9M

Vanda Pharmaceuticals Return On Invested Capital

  • Is Management Doing A Good Job?
    VNDA return on invested capital is -2.01%
  • What Is Vanda Pharmaceuticals Return On Assets?
    ROA measures how assets are converting to revenues and is -1.69%
  • What Is VNDA Return On Equity?
    ROE is a measure of profitability and is -2.01%

Vanda Pharmaceuticals Earnings Date & Stock Price

Vanda Pharmaceuticals Competitors

Vanda Pharmaceuticals Dividend Yield

Vanda Pharmaceuticals Analyst Estimates

YoY Growth Past Surprise
EPS: 0% 0%
Revenue: 9.59% 5.46%

Analyst Recommendations

Buy Recommendations: 1
Hold Recommendations: 1
Sell Recommendations: 0
Price Target: 10.55
Upside from Last Price: 120.3%

Major Shareholders

  • How many VNDA shares are owned by institutional investors?
    66.6M VNDA shares are owned by institutional investors
  • How many VNDA shares are owned by insiders?
    4M VNDA shares are owned by insiders